Adult's anaplastic CD30+ large cell lymphomas;Lymphomes anaplasiques T ou nuls a grandes cellules CD30+ (Ki-1) de l'adulte

Bulletin du Cancer

Volumn 86, Issue 9, 1999, Pages 739-744

  Cany, Laurent ^a   Soubeyran, Pierre ^c   Boulanger, Vincent ^c   Soubeyran, Isabelle ^c   Richaud, Pierre ^b   Eghbali, Houchingue ^c   Hoerni, Bernard ^c  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b INSTITUT BERGONIÉ   (France)

^c NONE

Author keywords

Anaplastic large cell lymphoma; CD30 (Ki 1) positive lymphoma; Chromosomal abnormality t(2; 5); Lymphomatoid papulosis

Indexed keywords

CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; CANCER CLASSIFICATION; CHROMOSOME TRANSLOCATION 2; CYTOGENETICS; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PROGNOSIS; REVIEW; SKIN LYMPHOMA; T CELL LYMPHOMA;

ADULT; ANTIGENS, CD30; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; PHENOTYPE; PROGNOSIS; SKIN NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0032833955     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. 1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue : evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985 ; 66: 848-58.
2. 2. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982 ; 299 : 65-7.
3. 3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994 ; 84 : 1361-92.
4. 4. Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997 ; 89 : 4514-20.
5. 5. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, et al. Primary anaplastic large-cell lymphoma in adults : clinical presentation, immunophenotype, and outcome. Blood 1997 ; 90 : 3727-34.
6. 6. Kadin ME. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 1994 ; 5 (suppl. 1): S25-S30.
7. 7. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996 ; 334 : 1238-48.
8. + (anaplastic) large-cell lymphoma : maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol 1994 ; 12: 884-7.
9. 9. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991 ; 9 : 539-47.
10. 10. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe MJ, et al. ALK-positive lymphoma : a single disease with a broad spectrum of morphology. Blood 1998 ; 91 : 2076-84.
11. + with a high content of reactive histiocytes). Histopathology 1990 ; 16 : 383-91.
12. + T-cell lymphoma. Am J Surg Pathol 1993 ; 17 : 859-68.
13. 13. Steín H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch HC. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann Oncol 1991 ; 2 (suppl. 2) : 33-8.
14. 14. Pileri SA, Milani M, Fraternali-Orcioni G, Sabattini E. From the Real classification to the upcoming WHO scheme : a step toward universal categorization of lymphoma entities? Ann Oncol 1998 ; 9 : 607-12.
15. 15. Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-and null-cell type and Hodgkin's disease : evidence for distinct cellular origin. Blood 1997 ; 89 : 980-9.
16. 16. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DM, Saltman DL, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994 ; 263 : 1281-4
17. 17. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, et al. Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994 ; 84 : 3648-52.
18. 18. Lamant L, Meggetto F, Al Saati T, Brugières L, Bressac de Paillerets B, Dastugue N, et al. High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transtriptase-polymetase chain reaction, and P-80 immunostaining. Blood 1996 ; 87 : 284-91.
19. 19. Weiss LM, Lopategui JR, Sun LH, Kamel OW, Chae HK, Glackin C. Absence of the t(2;5) in Hodgkin's disease. Blood 1995 ; 85 : 2845-7.
20. 20. Beylot-Barry M, Lamant L, Vergier B, Demuret A, Fraitag S, Delord B, et al. Detection of t(2;5) (p23;q.35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30 positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996 ; 149 : 483-92.
21. 21. De Coteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30(+) lymphoproliferative disorders : comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996 ; 87 : 3437-41.
22. 22. Fraga M, Brousset P, Schlaifer D, Payen C, Robert A, Rubie H, et al. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 1995 ; 103 : 82-9.
23. 23. Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic M. Lymphomatoid papulosis : a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intern Med 1995 ; 122 : 210-7.
24. 24. Willemze R, Meyer CJ, Van Vloten WA, Scheffer E. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 1982 ; 107 : 131-44.
25. 25. Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin. Clinicopathologic correlation and statistical analysis of 86 cases : a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Croup. J Clin Oncol 1995 ; 13 ; 1343-54.
26. 26. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, et al. Primary cutaneous CD30-positive large cell lymphoma : definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients. Cancer 1993 ; 71 : 2097-104.
27. 27. Brice P, Cazals D, Mounier N, Verola O, Neidhart-Berard AM, Remenieras L, et al. Primary cutaneous large-cell lymphoma : analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas, Leukemia 1998 ; 12 : 213-9.
28. 28. Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol 1993 ; 11 : 937-42.
29. 29. Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, et al. Anaplastic large-cell lymphoma : clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996 ; 14 : 955-62.
30. 30. Fanin R, Silvestri F, Geromin A, Cerno M, Infanti L, Zaja F, et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult : sequential intensive treatment with the F-MACHOP regimen (± radiotherapy) and autologous bone marrow transplantation. Blood 1996 ; 87 : 1243-8.
31. + anaplastic large-cell lymphoma. Blood 1995 ; 85 : 2139-46.
32. 32. Chow JM, Cheng AL, Su IJ, Wang CH. 13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma. Cancer 1991 ; 67 : 2490-3.
33. + anaplastic large-cell lymphoma through reinforcement of presumed T-cell-mediated tumor cell killing, complicated by unilateral drowning of lymphoma-infiltrated lung. J Immunother 1996 ; 19 : 162-7.
34. 34. Zinzani PL, Martelli M, Magagnoli M, Zaccaria A, Ronconi F, Cantonetti M, et al. Anaplastic large cell lymphoma Hodgkin's like : a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 1998 ; 92: 790-4.
35. + anaplastic large-cell lymphoma. J Clin Oncol 1995 ; 13 : 1355-60.
36. 36. Zinzani PL, Pileri S, Bendandi M, Buzzi M, Sabattini E, Ascani S, et al. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. J Clin Oncol 1998 ; 16 : 1532-7.
37. 37. Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A, et al. Peripheral T-cell lymphomas. Clinicopathologic study of 168 cases diagnosed according to the Real Classification. Ann Oncol 1997 ; 8 : 583-92.
38. 38. By the Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997 ; 89 : 3909-18.
39. 39. Armitage JO, Weisenburger DD for the Non-Hodgkin's Lymphoma Classification Project. New approach to classifying non-Hodgkin's lymphomas : clinical features of the major histologic subtypes. J Clin Oncol 1998 ; 16 : 2780-95.
40. 40. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993 ; 329 : 987-94.